Latest Breaking News On - Aramis rollover study - Page 1 : comparemela.com

Darolutamide given in an extended duration was linked with long-term clinical benefit and safety in patients with nonmetastatic castration-resistant prostate cancer.

United statesDarolutamide nubeqaCarolina urologic research centerCastration resistant prostate cancerProstate cancerAramis trialAramis rollover studyNeald shoreAua annual meeting